Physician

Richard Clifton Phinney, M.D.

According to 2025 Medicare claims, Richard Phinney, M.D. (NPI: 1215192703) practices hematology/oncology in the Toledo, OH market, with the plurality of this provider's patient population coming from Lucas, OH. This provider's primary affiliated billing organization is TOLEDO CLINIC INCORPORATED (NPI: 1144217894; TIN: 340936207) and primary practice location at 43537-9402. Phinney is affiliated with the Mercy Health Select, LLC (ACO ID: A1215) and CVS Accountable Care Organization, Inc. (ACO ID: D0061), participating under both the MSSP and REACH models.

Phinney's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 811 traditional Medicare patients, billed 239,946 HCPCS/CPT codes, and received $3,265,600 in Medicare payments. The top billing code was 96413 (Administration of chemotherapy into vein, 1 hour or less). Part D data shows 1,771 prescription claims across 379 beneficiaries totaling $4,949,119 in drug costs, led by Calquence (Acalabrutinib Maleate). 2023 DME data shows 13 claims. Open Payments data shows 5 records totaling $1,397. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $1,229,054 to $3,265,600. Similarly, Part D prescription costs have risen steadily, from $920,976 to $4,949,119. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	531	99,160	$1,229,054
2016	658	138,891	$1,605,185
2017	822	85,178	$1,588,382
2018	858	104,146	$1,499,944
2019	1,016	135,698	$2,189,055
2020	923	155,415	$2,997,341
2021	838	185,649	$2,134,849
2022	801	202,093	$2,415,637
2023	824	197,543	$2,551,007
2024	811	239,946	$3,265,600

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	190	896	$920,976
2016	229	1,132	$1,233,714
2017	328	1,828	$2,147,001
2018	369	1,932	$2,341,549
2019	387	2,079	$3,591,405
2020	405	2,241	$4,017,982
2021	418	2,231	$4,029,403
2022	398	1,961	$4,543,464
2023	378	1,882	$4,405,005
2024	379	1,771	$4,949,119

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	11	$207
2016	N/R	104	$27,029
2017	22	81	$23,182
2018	N/R	55	$8,727
2019	N/R	95	$11,570
2020	N/R	66	$5,760
2021	N/R	58	$5,191
2022	N/R	24	$946
2023	N/R	13	$245
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
96413	Administration of chemotherapy into vein, 1 hour or less	110	481	$90
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	357	730	$90
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	167	197	$61
96365	Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less	115	181	$43
96372	Injection of drug or substance under skin or into muscle	137	371	$10

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Calquence	Acalabrutinib Maleate	70	2,100	$1,018,398
Ibrance	Palbociclib	57	1,596	$874,144
Imbruvica	Ibrutinib	25	700	$440,925
Verzenio	Abemaciclib	27	762	$411,198
Cabometyx	Cabozantinib S-Malate	12	360	$301,311

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	5	$1,397	PFIZER INC.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Richard Clifton Phinney, M.D.?

Tedicare shows public-source Medicare data for Richard Clifton Phinney, M.D. (NPI 1215192703), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Richard Clifton Phinney, M.D. have ACO affiliation data?

Richard Clifton Phinney, M.D. is shown with ACO affiliation data for Mercy Health Select, LLC (MSSP, ACO ID A1215) and CVS Accountable Care Organization, Inc. (REACH, ACO ID D0061).

What billing organization is linked to Richard Clifton Phinney, M.D.?

Richard Clifton Phinney, M.D. is linked to TOLEDO CLINIC INCORPORATED (billing NPI 1144217894) in the available physician profile data.

Does Richard Clifton Phinney, M.D. have Open Payments data?

Richard Clifton Phinney, M.D. has 5 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.